|
FECH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.95929947213835E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.36130004438451E-10 |
| Normal-vs-Stage2 |
3.73480024684625E-10 |
| Normal-vs-Stage3 |
1.93649984936428E-10 |
| Normal-vs-Stage4 |
8.23609958011673E-10 |
| Stage1-vs-Stage2 |
5.491200E-01 |
| Stage1-vs-Stage3 |
9.261400E-01 |
| Stage1-vs-Stage4 |
9.240200E-01 |
| Stage2-vs-Stage3 |
6.604800E-01 |
| Stage2-vs-Stage4 |
7.327000E-01 |
| Stage3-vs-Stage4 |
9.762600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.13129966400538E-10 |
| Normal-vs-AfricanAmerican |
2.51749954216507E-10 |
| Normal-vs-Asian |
9.58320001132051E-09 |
| Caucasian-vs-AfricanAmerican |
9.410600E-01 |
| Caucasian-vs-Asian |
6.080000E-01 |
| AfricanAmerican-vs-Asian |
5.631200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.39870012741505E-10 |
| Normal-vs-Female |
4.84089990315795E-10 |
| Male-vs-Female |
9.508300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.88789983646132E-10 |
| Normal-vs-Extreme_Weight |
1.09219966404339E-10 |
| Normal-vs-Obese |
2.59749999287351E-10 |
| Normal-vs-Extreme_Obese |
1.75339999963775E-07 |
| Normal_Weight-vs-Extreme_Weight |
2.402200E-01 |
| Normal_Weight-vs-Obese |
7.743200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.130400E-01 |
| Extreme_Weight-vs-Obese |
1.972830E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.474800E-01 |
| Obese-vs-Extreme_Obese |
4.060600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.57109991683058E-10 |
| Normal-vs-Age(41-60Yrs) |
2.08490003039685E-10 |
| Normal-vs-Age(61-80Yrs) |
2.89420043486643E-10 |
| Normal-vs-Age(81-100Yrs) |
4.89419949012415E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.440800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.437200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.696200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.384000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.730200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.981600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.83180026702701E-10 |
| Normal-VS-Type2 PRCC |
5.41390043906631E-10 |
| Normal-VS-KIRP CIMP |
9.10510000728948E-09 |
| Normal-VS-Unclassified PRCC |
1.91979987462787E-10 |
| Type1 PRCC-VS-Type2 PRCC |
6.256200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.542250E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.491000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.647400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.500400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.133210E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.1390004191253E-11 |
| Normal-vs-N1 |
4.81440443067527E-11 |
| Normal-vs-N2 |
2.019300E-03 |
| N0-vs-N1 |
9.607400E-01 |
| N0-vs-N2 |
7.658800E-01 |
| N1-vs-N2 |
7.987200E-01 |
|
|
